SCHEMBL25439031

SCHEMBL25439031

O=C1OCCN1C(=O)OCOC1CC1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 8/20 0.39
FAAH O00519 4/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9586348 0.80 NAAA (0.51) NAAAFAAH
SCHEMBL4195675 0.71 NAAA (0.40) NAAAFAAH
SCHEMBL3362031 0.69 NAAA (0.46) NAAAFAAH
SCHEMBL22978758 0.68 ALDH1A1 (0.47)
SCHEMBL11681599 0.68 NAAA (0.60) NAAAFAAH
SCHEMBL31757364 0.66 MAPK1 (0.36)
SCHEMBL20707861 0.65 FAAH (0.59) NAAAFAAH
SCHEMBL7569177 0.65 NAAA (0.48) NAAAFAAH
SCHEMBL1563999 0.65 USP2 (0.49) NAAA
SCHEMBL15667494 0.64 NAAA (0.45) NAAAFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081858-A1 CONDENSED-PYRAZINE AMINE DERIVATIVES FOR TREATING SCA3 SKYHAWK THERAPEUTICS, INC. (US) 2023-05-11 WO disclosed